Skip to main content
Clinical Trials/JPRN-UMIN000007653
JPRN-UMIN000007653Completed未知

Clinical observation study of 5-year survivals in patients with newly diagnosed acute lymphoblastic leukemia (ALL) in Japan Adult Leukemia Study Group (JALSG). (JALSG-ALL-CS-12) - JALSG ALL clinical observation study 12 (JALSG-ALL-CS-12)

Japan Agency for Medical Research and Development Japan Adult Leukemia Study Group0 sites733 target enrollmentStarted: April 3, 2012Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
733

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
15years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •Past history of chemotherapy or stem cell transplantation in the treatment of A

Investigators

Sponsor
Japan Agency for Medical Research and Development Japan Adult Leukemia Study Group

Similar Trials